Prospectively Collected Pleural Biopsies for Validation of Malignant Pleural Mesothelioma
This research study is evaluating a new method for determining stage and prognosis of individuals with malignant pleural mesothelioma.
| Condition(s) | Mesothelioma |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | This research study is evaluating a new method for determining stage and prognosis of individuals with malignant pleural mesothelioma. |
| Who can participate | Inclusion Criteria: * All adult patients with a diagnosis of malignant pleural mesothelioma undergoing * diagnostic pleural biopsy * pleuroscopy * and/or VATS resections * Participants must be 18 years of age or older. Exclusion Criteria: -Any patient who is found to be unsuitable for * surgery, * treatment * diagnosis, |
| Ages | 18 Years |
| Sex | All |
| Lead sponsor | Dana-Farber Cancer Institute |
| Locations | Boston, Massachusetts, United States |
| Start date | 2018-10-31 |
| NCT ID | NCT03683680 |
| Official listing | https://clinicaltrials.gov/study/NCT03683680 |